跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,714 条关于
“I-SPY 2”
全部
91,714
临床试验
63,668
药物
8,294
机构
1,601
资讯
18,151
去年
I-SPY 2.2 Trial Design Shows Promise in Identifying Less Toxic Breast Cancer Therapies
2年前
I-SPY 2.2 Trial Revolutionizes Breast Cancer Treatment with Patient-Centered Design
去年
Signatera ctDNA Test Predicts Recurrence Risk in High-Risk Breast Cancer Patients, I-SPY 2 Trial Data Shows
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Lasofoxifene Shows Promise in Neoadjuvant Breast Cancer Treatment: I-SPY 2 Trial
去年
Lasofoxifene Shows Promise in Early Breast Cancer Treatment, I-SPY 2 Trial Data Reveal
去年
Atossa Therapeutics Streamlines Phase II Breast Cancer Trial Design While Advancing (Z)-Endoxifen Development
去年
Laura J. van 't Veer Honored with 2024 William L. McGuire Memorial Lecture Award for Breast Cancer Advancements
去年
Galera Therapeutics Completes Acquisition of Nova Pharmaceuticals
去年
Atossa's (Z)-Endoxifen Shows 77.7% Tumor Reduction in Phase 2 Breast Cancer Trial
第 1 页,共 1816 页
上一页
下一页